Liquid Biopsy Market to Register Incremental Revenue Opportunities During the Forecast Period 2021-2027

Market Research Engine has published a new report titled as “Liquid Biopsy Market Size By Application (Non-Cancer Applications, Cancer Applications), By End User (Academic and Research Centers, Hospitals and Physician Laboratories, Reference Laboratories, Other End Users), By Clinical Application (Early Cancer Screening, Recurrence Monitoring, Treatment Monitoring, Therapy Selection), By Product and Service (Instruments, Services, Assay Kits), By Circulating Biomarker (Extracellular Vesicles, Circulating Tumor Cells, Circulating Tumor Dna, Cell-Free Dna, Other Circulating Biomarkers), By Technology (Single Gene Analysis Using Pcr Microarrays, Multi-Gene-Parallel Analysis Using Ngs), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2020-2025.”

A liquid biopsy is fast ahead traction as a supplement or alternate to doing a tissue biopsy for applications in procreative health, cancer, and transplant medicine. The liquid biopsy techniques agree the physicians to comprehend the critical nature of the disease after the finding and screening procedure. The main biomarker kinds used in liquid biopsy contain circulating cell-free nucleic acids. Extracellular vesicles are a varied class of lipid-bound elements shed by any cell in the body in pathological and physiological conditions. Microarray technology has been widely used in cancer research for more than a period. Droplet Digital PCR agrees for the detection of target sequences which are contemporary in the very low background against other sequences present at high concentrations. Proteomics platforms include Mass Spectrometry and biochips. Deficiency of consensus on Standard Operating Measures and poor compensation structures are some of the main factors hindering the global liquid biopsy market. The compensation and treatment monitoring for liquid biopsy is limited, and it is achieved in a few laboratories. The poor reimbursement system is a important restraint which restricts the individuals to go for cancer detection tests and affects cancer biomarkers market negatively.

Browse Full Report: https://www.marketresearchengine.com/liquid-biopsy-market-report

The global Liquid Biopsy market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Liquid Biopsy market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Mdxhealth SA, Genomic Health, Inc., Raindance Technologies, Inc, Thermo Fisher Scientific Inc., Illumina, Inc., Biocept, Inc, Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc, and others are among the major players in the global Liquid Biopsy market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Liquid Biopsy Market has been segmented as below:

Liquid Biopsy Market, By Application

  • Non-Cancer Applications
  • Cancer Applications

Liquid Biopsy Market, By End User

  • Academic and Research Centers
  • Hospitals and Physician Laboratories
  • Reference Laboratories
  • Other End Users

Liquid Biopsy Market, By Clinical Application

  • Early Cancer Screening
  • Recurrence Monitoring
  • Treatment Monitoring
  • Therapy Selection

Liquid Biopsy Market, By Product and Service

  • Instruments
  • Services
  • Assay Kits

Liquid Biopsy Market, By Circulating Biomarker

  • Extracellular Vesicles
  • Circulating Tumor Cells
  • Circulating Tumor Dna
  • Cell-Free Dna
  • Other Circulating Biomarkers

Liquid Biopsy Market, By Technology

  • Single Gene Analysis Using Pcr Microarrays
  • Multi-Gene-Parallel Analysis Using Ngs

Liquid Biopsy Market, By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Liquid Biopsy Market, By Company

  • Mdxhealth SA
  • Genomic Health, Inc.
  • Raindance Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Biocept, Inc
  • Qiagen N.V.
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Myriad Genetics, Inc
  • Menarini-Silicon Biosystems
  • Trovagene, Inc.
  • Guardant Health, Inc.

 

The report covers:

  • Global Liquid Biopsy market sizes from 2015 to 2024, along with CAGR for 2019-2025
  • Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2025
  • Global Liquid Biopsy market trends, covering comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Liquid Biopsy market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
  • Comprehensive company profiles of the key industry players

Report Scope:

The global Liquid Biopsy market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Liquid Biopsy market share. Major industry players with significant revenue share include Mdxhealth SA, Genomic Health, Inc., Raindance Technologies, Inc, Thermo Fisher Scientific Inc., Illumina, Inc., Biocept, Inc, Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc, and others.

Reasons to Buy this Report:

  • Gain detailed insights on the Liquid Biopsy industry trends
  • Find complete analysis on the market status
  • Identify the Liquid Biopsy market opportunities and growth segments
  • Analyse competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Some of the recent developments in Liquid Biopsy Market are as follows:

Mdxhealth SA

  • 10-2019: MDxHealth is a multinational healthcare company which offers actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer.

 

  • 27-2018: MDxHealth SA declared the publication of positive data demonstrating the value of the SelectMDx liquid biopsy test for Prostate Cancer in guiding  patient management for men being considered for multiparametric MRI and the clinical utility in guiding biopsy decisions in real-world clinical practice.

Genomic Health, Inc.

  • 09-2014: Genomic Health, Inc. declared positive results from its first two feasibility studies assessing multiple technologies, including next-generation sequencing, for their ability to detect and characterize the presence of bladder cancer DNA in urine and breast cancer DNA in blood.
  • 11-2016: Genomic Health, Inc. declared plans to launch its first liquid biopsy test.

Customization

Customized report as per the requirement can be offered with appropriate recommendations

Request Sample Report from here:   https://www.marketresearchengine.com/liquid-biopsy-market-report

 Table of Contents:

  1. Introduction
    1.1 Key Insights
    1.2 Report Overview
    1.3 Markets Covered
    1.4 Stakeholders
  2. Research Methodology
    2.1 Research Scope
    2.2 Market Research Process
    2.3 Research Data Analysis
    2.4.1 Secondary Research
    2.4.2 Primary Research
    2.4.3 Models for Estimation
    2.5 Market Size Estimation
    2.5.1 Bottom-Up Approach – Segmental Market Analysis
    2.5.2 Top-Down Approach – Parent Market Analysis
  3. Executive Summary
  4. Market Overview
    4.1 Introduction
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.2.4 Challenges
    4.2 Porter’s Five Force Analysis

 

  1. Liquid Biopsy Market, By Application
    5.1 Introduction
    5.2 Non-Cancer Applications
    5.2.1 Market Overview
    5.2.2 Market Size and Forecast
    5.3 Cancer Applications
    5.3.1 Market Overview
    5.3.2 Market Size and Forecast
  2. Liquid Biopsy Market, By End User
    6.1 Introduction
    6.2 Academic and Research Centers
    6.2.1 Market Overview
    6.2.2 Market Size and Forecast
    6.3 Hospitals and Physician Laboratories
    6.3.1 Market Overview
    6.3.2 Market Size and Forecast
    6.4 Reference Laboratories
    6.4.1 Market Overview
    6.4.2 Market Size and Forecast
    6.5 Other End Users
    6.5.1 Market Overview
    6.5.2 Market Size and Forecast
  3. Liquid Biopsy Market, By Clinical Application
    7.1 Introduction
    7.2 Early Cancer Screening
    7.2.1 Market Overview
    7.2.2 Market Size and Forecast
    7.3 Recurrence Monitoring
    7.3.1 Market Overview
    7.3.2 Market Size and Forecast
    7.4 Treatment Monitoring
    7.4.1 Market Overview
    7.4.2 Market Size and Forecast
    7.5 Therapy Selection
    7.5.1 Market Overview
    7.5.2 Market Size and Forecast
  4. Liquid Biopsy Market, By Product and Service
    8.1 Introduction
    8.2 Instruments
    8.2.1 Market Overview
    8.2.2 Market Size and Forecast
    8.3 Services
    8.3.1 Market Overview
    8.3.2 Market Size and Forecast
    8.4 Assay Kits
    8.4.1 Market Overview
    8.4.2 Market Size and Forecast
  5. Liquid Biopsy Market, By Circulating Biomarker
    9.1 Introduction
    9.2 Extracellular Vesicles
    9.2.1 Market Overview
    9.2.2 Market Size and Forecast
    9.3 Circulating Tumor Cells
    9.3.1 Market Overview
    9.3.2 Market Size and Forecast
    9.4 Circulating Tumor Dna
    9.4.1 Market Overview
    9.4.2 Market Size and Forecast
    9.5 Cell-Free Dna
    9.5.1 Market Overview
    9.5.2 Market Size and Forecast
    9.6 Other Circulating Biomarkers
    9.6.1 Market Overview
    9.6.2 Market Size and Forecast
  6. Liquid Biopsy Market, By Technology
    10.1 Introduction
    10.2 Single Gene Analysis Using Pcr Microarrays
    10.2.1 Market Overview
    10.2.2 Market Size and Forecast
    10.3 Multi-Gene-Parallel Analysis Using Ngs
    10.3.1 Market Overview
    10.3.2 Mrket Size and Forecast
  7. Liquid Biopsy Market, By Geography
    11.1 Introduction
    11.2 North America
    11.2.1 North America Liquid Biopsy, By Application
    11.2.2 North America Liquid Biopsy, By End User
    11.2.3 North America Liquid Biopsy, By Clinical Application
    11.2.4 North America Liquid Biopsy, By Product and Service
    11.2.5 North America Liquid Biopsy, By Circulating Biomarker
    11.2.6 North America Liquid Biopsy, By Technology
    11.3 Europe
    11.3.1 Europe Liquid Biopsy, By Application
    11.3.2 Europe Liquid Biopsy, By End User
    11.3.3 Europe Liquid Biopsy, By Clinical Application
    11.3.4 Europe Liquid Biopsy, By Product and Service
    11.3.5 Europe Liquid Biopsy, By Circulating Biomarker
    11.3.6 Europe Liquid Biopsy, By Technology
    11.4 Asia-Pacific
    11.4.1 Asia-Pacific Liquid Biopsy, By Application
    11.4.2 Asia-Pacific Liquid Biopsy, By End User
    11.4.3 Asia-Pacific Liquid Biopsy, By Clinical Application
    11.4.4 Asia-Pacific Liquid Biopsy, By Product and Service
    11.4.5 Asia-Pacific Liquid Biopsy, By Circulating Biomarker
    11.4.6 Asia-Pacific Liquid Biopsy, By Technology
    11.5 Rest of the World
    11.5.1 Rest of the World Liquid Biopsy, By Application
    11.5.2 Rest of the World Liquid Biopsy, By End User
    11.5.3 Rest of the World Liquid Biopsy, By Clinical Application
    11.5.4 Rest of the World Liquid Biopsy, By Product and Service
    11.5.5 Rest of the World Liquid Biopsy, By Circulating Biomarker
    11.5.6 Rest of the World Liquid Biopsy, By Technology
    12. Competitive Insights
    12.1 Key Insights
    12.2 Company Market Share Analysis
    12.3 Strategic Outlook
    12.3.1 Mergers & Acquisitions
    12.3.2 New Product Development
    12.3.3 Portfolio/Production Capacity Expansions
    12.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
    12.3.5 Others
    13. Company Profiles
    13.1 Mdxhealth SA
    13.1.1 Company Overview
    13.1.2 Product/Service Landscape
    13.1.3 Financial Overview
    13.1.4 Recent Developments
    13.2 Genomic Health, Inc.
    13.2.1 Company Overview
    13.2.2 Product/Service Landscape
    13.2.3 Financial Overview
    13.2.4 Recent Developments
    13.3 Raindance Technologies, Inc
    13.3.1 Company Overview
    13.3.2 Product/Service Landscape
    13.3.3 Financial Overview
    13.3.4 Recent Developments
    13.4 Thermo Fisher Scientific Inc.
    13.4.1 Company Overview
    13.4.2 Product/Service Landscape
    13.4.3 Financial Overview
    13.4.4 Recent Developments
    13.5 Illumina, Inc.
    13.5.1 Company Overview
    13.5.2 Product/Service Landscape
    13.5.3 Financial Overview
    13.5.4 Recent Developments
    13.6 Biocept, Inc
    13.6.1 Company Overview
    13.6.2 Product/Service Landscape
    13.6.3 Financial Overview
    13.6.4 Recent Developments
    13.7 Qiagen N.V.
    13.7.1 Company Overview
    13.7.2 Product/Service Landscape
    13.7.3 Financial Overview
    13.7.4 Recent Developments
    13.8 Roche Diagnostics
    13.8.1 Company Overview
    13.8.2 Product/Service Landscape
    13.8.3 Financial Overview
    13.8.4 Recent Developments
    13.9 Bio-Rad Laboratories, Inc.
    13.9.1 Company Overview
    13.9.2 Product/Service Landscape
    13.9.3 Financial Overview
    13.9.4 Recent Developments
    13.10 Myriad Genetics, Inc
    13.10.1 Company Overview
    13.10.2 Product/Service Landscape
    13.10.3 Financial Overview
    13.10.4 Recent Developments
    13.11 Menarini-Silicon Biosystems
    13.11.1 Company Overview
    13.11.2 Product/Service Landscape
    13.11.3 Financial Overview
    13.11.4 Recent Developments
    13.12 Trovagene, Inc.
    13.12.1 Company Overview
    13.12.2 Product/Service Landscape
    13.12.3 Financial Overview
    13.12.4 Recent Developments
    13.13 Guardant Health, Inc
    13.13.1 Company Overview
    13.13.2 Product/Service Landscape
    13.13.3 Financial Overview
    13.13.4 Recent Developments

Other Related Market Research Reports:

Image Sensor Market Global Opportunity Analysis and Industry Forecast 2020-2025

LMS Market Global Opportunity Analysis and Industry Forecast 2020-2025

Nutraceutical Ingredients Market Global Opportunity Analysis and Industry Forecast 2020-2025

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/